Avadel Pharmaceuticals Plc

D. E. Shaw & Co., Inc. AVDL

Report date

12/31/2023

Quarter

2023 Q4

Filed

2/14/2024

Shares

196,554

Value ($000)

2,775

Weight

0.0%

2019 Q4 - 2023 Q4 (12 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q4	2/14/2024	2,775	0.0%	196,554	12/31/2023
2023 Q3	11/14/2023	5,659	0.0%	549,370	9/30/2023
2023 Q2	8/14/2023	12,621	0.0%	765,836	6/30/2023
2023 Q1	5/15/2023	2,851	0.0%	311,290	3/31/2023
2022 Q4	2/14/2023	2,461	0.0%	343,755	12/31/2022
2022 Q3	11/14/2022	1,764	0.0%	352,114	9/30/2022
2022 Q2	8/15/2022	33	0.0%	13,432	6/30/2022
2021 Q3	11/15/2021	324	0.0%	33,041	9/30/2021
2021 Q2	8/16/2021	92	0.0%	13,636	6/30/2021
2020 Q3	11/16/2020	103	0.0%	20,342	9/30/2020
2020 Q2	8/14/2020	779	0.0%	96,414	6/30/2020
2019 Q4	2/14/2020	107	0.0%	14,118	12/31/2019